Iovance Biotherapeutics
Ahmed Tawashi has worked at various pharmaceutical companies in different roles over the years, demonstrating expertise in clinical operations and research alliances. With a background in Physiology from McGill University, Ahmed has held positions such as Vice President, Executive Director, and Director in companies like Iovance Biotherapeutics, Pharmacyclics, and Affymax, Inc. Ahmed's extensive experience in clinical trials and medical affairs has contributed to their success in the pharmaceutical industry.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.